News
-
BusinessNEW 【Mitsubishi Tanabe Pharma】Filling for a Oral Edaravone Formulation for the treatment of ALS in Korea
-
InformationNEW Transcript of Financial Results Presentation for the Third Quarter of Fiscal Year Ending March 31, 2025
-
BusinessGlobal Impact Coalition Launches Automotive Plastics Circularity Pilot Project in Europe with Seven Leading Companies from Chemical and Recycling Industries
-
Business【Mitsubishi Tanabe Pharma】Regulatory Approval of Cariprazine (MP-214) For Adjunctive therapy for major depressive disorder in Thailand
-
InformationPresentation Material : Sustainability Briefing 2025
-
BusinessNEW 【Mitsubishi Tanabe Pharma】Filling for a Oral Edaravone Formulation for the treatment of ALS in Korea
-
BusinessGlobal Impact Coalition Launches Automotive Plastics Circularity Pilot Project in Europe with Seven Leading Companies from Chemical and Recycling Industries
-
Business【Mitsubishi Tanabe Pharma】Regulatory Approval of Cariprazine (MP-214) For Adjunctive therapy for major depressive disorder in Thailand
-
BusinessMitsubishi Chemical Group’s Prepreg Using Plant-Derived Resin Acquires International Sustainability and Carbon Certification ISCC PLUS - Contributing to the reduction of environmental impacts in areas ranging from sports and leisure to mobility and industrial applications -
-
Business【Mitsubishi Tanabe Pharma】EMA Accepts Marketing Authorization Application for ND0612, an Investigational Treatment for Motor Fluctuations in Parkinson’s Disease
-
InformationNEW Transcript of Financial Results Presentation for the Third Quarter of Fiscal Year Ending March 31, 2025
-
InformationPresentation Material : Sustainability Briefing 2025
-
InformationConference Video : Transaction Overview ― Transfer of Mitsubishi Tanabe Pharma Corporation
-
InformationPresentation Material : Transaction Overview ー Transfer of Mitsubishi Tanabe Pharma Corporation
-
InformationConference Video of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2025
-
IR NewsNEW Transcript of Financial Results Presentation for the Third Quarter of Fiscal Year Ending March 31, 2025
-
IR NewsPresentation Material : Sustainability Briefing 2025
-
TSE Filings“Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2025 (Under IFRS)” Partial Corrections in Disclosure Matters And Completion of Interim Review for by an Independent Auditor
-
IR NewsConference Video : Transaction Overview ― Transfer of Mitsubishi Tanabe Pharma Corporation
-
TSE FilingsNotice Concerning the Transfer of Mitsubishi Tanabe Pharma Corporation and its Subsidiaries
Corporate Information
Group information on Mitsubishi Chemical Group Corporation, which is confronting uncertainty with a continued transformation.
Investor Relations
About IR information of Mitsubishi Chemical Group Corporation, which is enhancing its asset efficiency and refortifying its financial base in an effort to enhance corporate value.
Innovation
We introduce the innovations of the Mitsubishi Chemical Group, which we are pursuing as a driving force that supports sustained growth, across industries and across countries.
Sustainability
The Mitsubishi Chemical Group will work on solving social issues through business activities, contribute to the sustainable development of the global environment and society, and realize the Group’s sustainable growth.
Related Contents
